An overwhelming body of clinical evidence shows that semaglutide is superior to liraglutide (a weight loss medication) in reducing body weight and blood sugar levels: Tirzepatide and semaglutide are both GLP-1 receptor agonists, which means they work by binding to the GLP-1 receptor in the gut to help control blood sugar levels
Diabetes Ther (2021) 12:80111
Read the full Terms and Conditions before relying on this feature as a safety net
GLP-1 medications have generally been well-tolerated for long-term use, though they may have mild to moderate side effects such as nausea, vomiting, diarrhea, abdominal discomfort, or occasional constipation
Regular Monitoring : Our team will provide ongoing support and monitoring to ensure optimal results and address any concerns
Eligibility varies by specific trial but generally includes adults with BMI 27-30, often with obesity-related comorbidities